Matches in Wikidata for { <http://www.wikidata.org/entity/Q66343745> ?p ?o ?g. }
Showing items 1 to 39 of
39
with 100 items per page.
- Q66343745 description "clinical trial" @default.
- Q66343745 description "ensayu clínicu" @default.
- Q66343745 description "klinisch onderzoek" @default.
- Q66343745 description "клінічне випробування" @default.
- Q66343745 name "Effects of Gemigliptin Versus Sitagliptin or Glimepiride With Metformin on Glucose Variability(MAGE, Glucose SD) Patients With Type 2 DM(STABLE Study)" @default.
- Q66343745 name "Effects of Gemigliptin Versus Sitagliptin or Glimepiride With Metformin on Glucose Variability(MAGE, Glucose SD) Patients With Type 2 DM(STABLE Study)" @default.
- Q66343745 type Item @default.
- Q66343745 label "Effects of Gemigliptin Versus Sitagliptin or Glimepiride With Metformin on Glucose Variability(MAGE, Glucose SD) Patients With Type 2 DM(STABLE Study)" @default.
- Q66343745 label "Effects of Gemigliptin Versus Sitagliptin or Glimepiride With Metformin on Glucose Variability(MAGE, Glucose SD) Patients With Type 2 DM(STABLE Study)" @default.
- Q66343745 prefLabel "Effects of Gemigliptin Versus Sitagliptin or Glimepiride With Metformin on Glucose Variability(MAGE, Glucose SD) Patients With Type 2 DM(STABLE Study)" @default.
- Q66343745 prefLabel "Effects of Gemigliptin Versus Sitagliptin or Glimepiride With Metformin on Glucose Variability(MAGE, Glucose SD) Patients With Type 2 DM(STABLE Study)" @default.
- Q66343745 P1050 Q66343745-F9586D7A-293B-403C-ABCC-DDBEC9945D08 @default.
- Q66343745 P1132 Q66343745-12FEB5B3-90E3-40D3-8DE4-3F10A5F4A9E2 @default.
- Q66343745 P1476 Q66343745-50FC0BD6-5D8B-41B5-A692-707F896ACDF5 @default.
- Q66343745 P1813 Q66343745-5E4E7334-5BA7-4932-8AA6-F281B6320510 @default.
- Q66343745 P2899 Q66343745-35A63EC0-EC48-47FA-8D90-87F3E079F6A8 @default.
- Q66343745 P3098 Q66343745-DB1AF817-9223-4016-BA16-67881D7B86E0 @default.
- Q66343745 P31 Q66343745-5E1911EE-296F-482A-806A-1A09D27A03B1 @default.
- Q66343745 P4135 Q66343745-2193174A-4478-45DB-96BA-C20050694822 @default.
- Q66343745 P4844 Q66343745-5079962B-55A0-4C81-92DE-73502FF047F8 @default.
- Q66343745 P4844 Q66343745-93439DCD-08E2-486B-9EF3-65CC33A2F381 @default.
- Q66343745 P580 Q66343745-A004330A-8D97-4625-B341-8F24C3621EA2 @default.
- Q66343745 P582 Q66343745-1B11231C-7019-471A-AC6C-EDF5CDE8289C @default.
- Q66343745 P6099 Q66343745-9FC713AE-F084-4292-8A11-4D7CF118B806 @default.
- Q66343745 P8363 Q66343745-BA2B0597-F7F5-48B8-9EA2-232DF3587D58 @default.
- Q66343745 P1050 Q12206 @default.
- Q66343745 P1132 "+69" @default.
- Q66343745 P1476 "A Multicenter, Randomized, Active-controlled, Parallel Group, Open-label, Exploratory Study to Evaluate the Efficacy on Glucose Variability(MAGE, Glucose SD) and Safety of Initial Combination Therapy of Gemigliptin 50mg q.d., Versus Sitagliptin 100mg q.d., or Glimepiride 2mg q.d. With Metformin 500-1,000mg q.d. in Patients With Type 2 Diabetes" @default.
- Q66343745 P1813 "STABLE" @default.
- Q66343745 P2899 "+20" @default.
- Q66343745 P3098 "NCT01890629" @default.
- Q66343745 P31 Q30612 @default.
- Q66343745 P4135 "+70" @default.
- Q66343745 P4844 Q19484 @default.
- Q66343745 P4844 Q425027 @default.
- Q66343745 P580 "2013-05-01T00:00:00Z" @default.
- Q66343745 P582 "2014-08-01T00:00:00Z" @default.
- Q66343745 P6099 Q42825046 @default.
- Q66343745 P8363 Q78089383 @default.